BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JK, Seok JK, Cho I, Yang G, Kim KB, Kwack SJ, Kang HC, Cho YY, Lee HS, Lee JY. Topical application of celastrol alleviates atopic dermatitis symptoms mediated through the regulation of thymic stromal lymphopoietin and group 2 innate lymphoid cells. J Toxicol Environ Health A 2021;:1-10. [PMID: 34304725 DOI: 10.1080/15287394.2021.1955785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yao C, Ye W, Chen M. Inhibition of Mast Cell Degranulation in Atopic Dermatitis by Celastrol through Suppressing MRGPRX2. Dis Markers 2023;2023:9049256. [PMID: 36712922 DOI: 10.1155/2023/9049256] [Reference Citation Analysis]
2 Li SZ, Jin XX, Shan Y, Jin HZ, Zuo YG. Expression of Thymic Stromal Lymphopoietin in Immune-Related Dermatoses. Mediators Inflamm 2022;2022:9242383. [PMID: 36046760 DOI: 10.1155/2022/9242383] [Reference Citation Analysis]
3 Zhi W, Li C, Zhang H, Zhao Y, Zong S, Liu Q, Zhou J, Wang C, Sun T, Liu Y, Li Y. Ta-Xi-San Suppresses Atopic Dermatitis Involved in Multitarget Mechanism Using Experimental and Network Pharmacology Analysis. Evid Based Complement Alternat Med 2022;2022:8441938. [PMID: 35646146 DOI: 10.1155/2022/8441938] [Reference Citation Analysis]
4 Rodrigues de Souza I, Savio de Araujo-Souza P, Morais Leme D. Genetic variants affecting chemical mediated skin immunotoxicity. J Toxicol Environ Health B Crit Rev 2022;25:43-95. [PMID: 34979876 DOI: 10.1080/10937404.2021.2013372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]